Phase II trial of IMO 8400 in patients with lupus.
Phase of Trial: Phase II
Latest Information Update: 28 May 2013
At a glance
- Drugs IMO 8400 (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 28 May 2013 Planned initiation date changed to 1 Dec 2013.
- 16 Nov 2012 New trial record